Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands		3 Months Ended				6 Months Ended		12 Months Ended
		Nov. 30, 2016		Nov. 30, 2015		Nov. 30, 2016	Nov. 30, 2015	May 31, 2016
Net sales		$ 93,676		$ 96,249		$ 192,269	$ 192,961
Cost of sales (*)	[2]	38,170	[1]	37,888	[1]	74,631	72,529
Gross profit		55,506		58,361		117,638	120,432
Operating expenses:
Research and development		8,800		6,760		17,797	13,590
Selling and marketing		15,405		14,819		30,492	28,806
Distribution		4,463		4,395		8,565	8,814
General and administrative		10,514		10,608		22,064	21,354
Amortization expense		14,126		13,591		28,306	27,169
Total operating expenses		53,308		50,173		107,224	99,733
Income from operations		2,198		8,188		10,414	20,699
Non-operating income (expense):
Interest income		8		41		14	83
Interest expense		(23,127)		(22,454)		(46,229)	(44,946)
Other, net		45		78		(554)	(50)
Total non-operating expense		(23,074)		(22,335)		(46,769)	(44,913)
Loss before income taxes		(20,876)		(14,147)		(36,355)	(24,214)
Benefit for income taxes		(8,121)		(2,351)		(13,497)	(5,201)
Net loss		(12,755)		(11,796)		(22,858)	(19,013)	$ (43,767)
Net loss attributable to noncontrolling interest		(1,542)				(2,986)
Net loss attributable to shareholders of Immucor, Inc.		(11,213)		(11,796)		(19,872)	(19,013)
Net sales		93,676		96,249		192,269	192,961
Cost of sales (*)	[2]	38,170	[1]	37,888	[1]	74,631	72,529
Gross profit		$ 55,506		$ 58,361		$ 117,638	$ 120,432

[1] Cost of sales is exclusive of amortization expense which is shown separately within operating expenses.

[2] Cost of sales is exclusive of amortization expense which is shown separately within operating expenses.